Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheinberg

Showing results (341-350 of 426) with videos related to

Pageof 43
Sort By:
Journal of Biomolecular Screening|April 17, 2007
High-throughput identification of inhibitors of human mitochondrial peptide deformylaseChristophe Antczak, David Shum, Sindy Escobar, et al.
Cancer Immunology Research|September 22, 2019
ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor ImmunopeptidomeClaire Y Oh, Martin G Klatt, Christopher Bourne, et al.
Genes & Development|June 19, 2007
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularizationDaniel J Nolan, Alessia Ciarrocchi, Albert S Mellick, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2010
Paradoxical glomerular filtration of carbon nanotubesAlessandro Ruggiero, Carlos H Villa, Evan Bander, et al.
ACS Nano|June 21, 2011
Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigensCarlos H Villa, Tao Dao, Ian Ahearn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphomaM S Czuczman, D J Straus, C R Divgi, et al.
Cancer|September 5, 2002
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemiaMark A Weiss, Timothy B Aliff, Martin S Tallman, et al.
Plos One|March 8, 2007
Selective alpha-particle mediated depletion of tumor vasculature with vascular normalizationJaspreet Singh Jaggi, Erik Henke, Surya V Seshan, et al.
Science Translational Medicine|March 25, 2016
Targeted fibrillar nanocarbon RNAi treatment of acute kidney injurySimone Alidori, Nima Akhavein, Daniel L J Thorek, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancerTao Dao, Martin G Klatt, Tatyana Korontsvit, et al.
Pageof 43

Showing results (341-350 of 426) with videos related to

Sort By:
Pageof 43
Journal of Biomolecular Screening|April 17, 2007
High-throughput identification of inhibitors of human mitochondrial peptide deformylaseChristophe Antczak, David Shum, Sindy Escobar, et al.
Cancer Immunology Research|September 22, 2019
ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor ImmunopeptidomeClaire Y Oh, Martin G Klatt, Christopher Bourne, et al.
Genes & Development|June 19, 2007
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularizationDaniel J Nolan, Alessia Ciarrocchi, Albert S Mellick, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2010
Paradoxical glomerular filtration of carbon nanotubesAlessandro Ruggiero, Carlos H Villa, Evan Bander, et al.
ACS Nano|June 21, 2011
Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigensCarlos H Villa, Tao Dao, Ian Ahearn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphomaM S Czuczman, D J Straus, C R Divgi, et al.
Cancer|September 5, 2002
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemiaMark A Weiss, Timothy B Aliff, Martin S Tallman, et al.
Plos One|March 8, 2007
Selective alpha-particle mediated depletion of tumor vasculature with vascular normalizationJaspreet Singh Jaggi, Erik Henke, Surya V Seshan, et al.
Science Translational Medicine|March 25, 2016
Targeted fibrillar nanocarbon RNAi treatment of acute kidney injurySimone Alidori, Nima Akhavein, Daniel L J Thorek, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancerTao Dao, Martin G Klatt, Tatyana Korontsvit, et al.
Pageof 43